Aripiprazole versus typical antipsychotic drugs for schizophrenia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aripiprazole Versus Typical Antipsychotic Drugs for Schizophrenia: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433398/all/Combined_psychotherapy_plus_antidepressants_for_panic_disorder_with_or_without_agoraphobia_Edited__no_change_to_conclusions_.
Aripiprazole versus typical antipsychotic drugs for schizophrenia: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433398/all/Combined_psychotherapy_plus_antidepressants_for_panic_disorder_with_or_without_agoraphobia_Edited__no_change_to_conclusions_. Accessed February 15, 2025.
Aripiprazole versus typical antipsychotic drugs for schizophrenia: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433398/all/Combined_psychotherapy_plus_antidepressants_for_panic_disorder_with_or_without_agoraphobia_Edited__no_change_to_conclusions_
Aripiprazole Versus Typical Antipsychotic Drugs for Schizophrenia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433398/all/Combined_psychotherapy_plus_antidepressants_for_panic_disorder_with_or_without_agoraphobia_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aripiprazole versus typical antipsychotic drugs for schizophrenia: Cochrane systematic review
ID - 433398
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433398/all/Combined_psychotherapy_plus_antidepressants_for_panic_disorder_with_or_without_agoraphobia_Edited__no_change_to_conclusions_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -